Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents
Zhen Wang, Juan Zhang, Conghao Gai, Jing Wang, Xiaobin Zhuo, Yan Song, Yan Zou, Peichao Zhang, Guige Hou, Qingguo Meng, Qingjie Zhao, Xiaoyun Chai
TL;DR
This paper corrects a previously published study on new anti-inflammatory compounds derived from lignan LCA.
Contribution
The paper provides corrections to prior research on dibenzylbutane lignan LCA derivatives.
Findings
The original study's findings on anti-inflammatory agents are being corrected.
The corrections address errors in the previously published work.
Abstract
Correction for ‘Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents’ by Zhen Wang et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d4md00053f.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBiological Activity of Diterpenoids and Biflavonoids · Plant-derived Lignans Synthesis and Bioactivity · Flavonoids in Medical Research